{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:21:27Z","timestamp":1781180487103,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:00:00Z","timestamp":1307404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10620-011-1719-6","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T05:44:10Z","timestamp":1307339050000},"page":"2939-2946","source":"Crossref","is-referenced-by-count":35,"title":["Double-Blind Randomized Controlled Trial of Rifaximin for Persistent Symptoms in Patients with Celiac Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Matthew S.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Minaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H. R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,7]]},"reference":[{"key":"1719_CR1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","volume":"357","author":"P Green","year":"2007","unstructured":"Green P, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731\u20131743.","journal-title":"N Engl J Med"},{"key":"1719_CR2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2036.1996.66237000.x","volume":"10","author":"S O\u2019Mahony","year":"1996","unstructured":"O\u2019Mahony S, Howdle P, Losowsky M. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671\u2013680.","journal-title":"Aliment Pharmacol Ther"},{"key":"1719_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11894-007-0049-5","volume":"9","author":"H Abdallah","year":"2007","unstructured":"Abdallah H, Leffler D, Dennis M, Kelly C. Refractory celiac disease. Curr Gastroenterol Rep. 2007;9:401\u2013405.","journal-title":"Curr Gastroenterol Rep"},{"key":"1719_CR4","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1053\/gast.1997.v112.pm9178673","volume":"112","author":"KD Fine","year":"1997","unstructured":"Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology. 1997;112:1830\u20131838.","journal-title":"Gastroenterology"},{"key":"1719_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MCG.0b013e3181557e67","volume":"43","author":"A Rubio-Tapia","year":"2009","unstructured":"Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43:157\u2013161.","journal-title":"J Clin Gastroenterol"},{"key":"1719_CR6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1572-0241.2003.07379.x","volume":"98","author":"A Tursi","year":"2003","unstructured":"Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839\u2013843.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR7","first-page":"159","volume":"28","author":"SV Rana","year":"2007","unstructured":"Rana SV, Sinha SK, Lal S, Sikander A, Singh K. Small intestinal bacterial overgrowth in North Indian patients with celiac disease. Trop Gastroenterol. 2007;28:159\u2013161.","journal-title":"Trop Gastroenterol"},{"key":"1719_CR8","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1572-0241.2002.05917.x","volume":"97","author":"AS Abdulkarim","year":"2002","unstructured":"Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016\u20132021.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR9","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/ajcn\/23.12.1602","volume":"23","author":"R Prizont","year":"1970","unstructured":"Prizont R, Hersh T, Floch MH. Jejunal bacterial flora in chronic small bowel disease. I. Celiac disease. II. Regional enteritis. Am J Clin Nutr. 1970;23:1602\u20131607.","journal-title":"Am J Clin Nutr"},{"key":"1719_CR10","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1053\/j.gastro.2005.11.046","volume":"130","author":"E Quigley","year":"2006","unstructured":"Quigley E, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130:S78\u2013S90.","journal-title":"Gastroenterology"},{"key":"1719_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/00365520801947074","volume":"43","author":"S Rana","year":"2008","unstructured":"Rana S, Bhardwaj S. Small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008;43:1030\u20131037.","journal-title":"Scand J Gastroenterol"},{"key":"1719_CR12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0016-5085(90)90818-L","volume":"98","author":"G Corazza","year":"1990","unstructured":"Corazza G, Menozzi M, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302\u2013309.","journal-title":"Gastroenterology"},{"key":"1719_CR13","doi-asserted-by":"crossref","unstructured":"Ghoshal U, Ghoshal U, Misra A, Choudhuri G. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol. 2004;10.","DOI":"10.1186\/1471-230X-4-10"},{"key":"1719_CR14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF02233506","volume":"11","author":"WM Roufail","year":"1966","unstructured":"Roufail WM, Ruffin JM. Effect of antibiotic therapy on gluten-sensitive enteropathy. Am J Dig Dis. 1966;11:587\u2013593.","journal-title":"Am J Dig Dis"},{"key":"1719_CR15","doi-asserted-by":"crossref","unstructured":"Pelosini I, Scarpignato C. Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract. Chemotherapy. 2005;122\u2013130.","DOI":"10.1159\/000081999"},{"key":"1719_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2005.02516.x","volume":"22","author":"E Lauritano","year":"2005","unstructured":"Lauritano E, Gabrielli M, Lupascu A, et al. Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005;22:31\u201335.","journal-title":"Aliment Pharmacol Ther"},{"key":"1719_CR17","doi-asserted-by":"crossref","unstructured":"Scarpellini E, Gabrielli M, Lauritano E, et al. High-dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007;25:781\u2013786.","DOI":"10.1111\/j.1365-2036.2007.03259.x"},{"key":"1719_CR18","doi-asserted-by":"crossref","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129\u2013134.","DOI":"10.1007\/BF01535722"},{"key":"1719_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","volume":"101","author":"AI Sharara","year":"2006","unstructured":"Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101:326\u2013333.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR20","first-page":"412","volume":"98","author":"M Pimentel","year":"2003","unstructured":"Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412\u2013419.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0016-5085(87)90313-1","volume":"93","author":"GR Corazza","year":"1987","unstructured":"Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987;93:53\u201358.","journal-title":"Gastroenterology"},{"key":"1719_CR22","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","volume":"95","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503\u20133506.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1572-0241.2005.40795.x","volume":"100","author":"B Walters","year":"2005","unstructured":"Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566\u20131570.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","volume":"18","author":"M Pimentel","year":"2009","unstructured":"Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349\u2013358.","journal-title":"Expert Opin Investig Drugs"},{"key":"1719_CR25","first-page":"105","volume":"5","author":"K Mustalahti","year":"2002","unstructured":"Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, M\u00e4ki M. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 2002;5:105\u2013113.","journal-title":"Eff Clin Pract"},{"key":"1719_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/003655200750023002","volume":"35","author":"S Lohiniemi","year":"2000","unstructured":"Lohiniemi S, M\u00e4ki M, Kaukinen K, Laippala P, Collin P. Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets. Scand J Gastroenterol. 2000;35:947\u2013949.","journal-title":"Scand J Gastroenterol"},{"key":"1719_CR27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/003655298750026949","volume":"33","author":"C Hallert","year":"1998","unstructured":"Hallert C, Granno C, Grant C, et al. Quality of life of adult coeliac patients treated for 10\u00a0years. Scand J Gastroenterol. 1998;33:933\u2013938.","journal-title":"Scand J Gastroenterol"},{"key":"1719_CR28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/MEG.0b013e3283267941","volume":"21","author":"EG Hopman","year":"2009","unstructured":"Hopman EG, Koopman HM, Wit JM, Mearin ML. Dietary compliance and health-related quality of life in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2009;21:1056\u20131061.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1719_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cgh.2010.06.017","volume":"9","author":"F Nachman","year":"2011","unstructured":"Nachman F, Vazquez H, Gonzalez A, et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol. 2011;9:214\u2013219.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1719_CR30","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1572-0241.2003.07632.x","volume":"98","author":"G Midhagen","year":"2003","unstructured":"Midhagen G, Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol. 2003;98:2023\u20132026.","journal-title":"Am J Gastroenterol"},{"key":"1719_CR31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22\u201332.","journal-title":"N Engl J Med"},{"key":"1719_CR32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2006.12.006","volume":"5","author":"D Leffler","year":"2007","unstructured":"Leffler D, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly C. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445\u2013450.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1719_CR33","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s10620-010-1342-y","volume":"55","author":"SD Dorn","year":"2010","unstructured":"Dorn SD, Hernandez L, Minaya MT, et al. Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center. Dig Dis Sci. 2010;55:3154\u20133163.","journal-title":"Dig Dis Sci"},{"key":"1719_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000103892","volume":"25","author":"A Gasbarrini","year":"2007","unstructured":"Gasbarrini A, Lauritano E, Gabrielli M, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007;25:237\u2013240.","journal-title":"Dig Dis"},{"key":"1719_CR35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","volume":"53","author":"R Khoshini","year":"2008","unstructured":"Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443\u20131454.","journal-title":"Dig Dis Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1719-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1719-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T08:39:33Z","timestamp":1560242373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1719-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,7]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1719-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,7]]}}}